Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 10384822)

1.

Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Gencel VB, Benjamin MM, Bahou SN, Khalil RA.

Mini Rev Med Chem. 2012 Feb;12(2):149-74. Review.

2.

Phytoestrogen biological actions on Mammalian reproductive system and cancer growth.

Zhao E, Mu Q.

Sci Pharm. 2011 Mar;79(1):1-20. doi: 10.3797/scipharm.1007-15. Epub 2010 Dec 31.

3.

Dietary lignans: physiology and potential for cardiovascular disease risk reduction.

Peterson J, Dwyer J, Adlercreutz H, Scalbert A, Jacques P, McCullough ML.

Nutr Rev. 2010 Oct;68(10):571-603. doi: 10.1111/j.1753-4887.2010.00319.x. Review.

4.

The response of creatine kinase specific activity in rat pituitary to estrogenic compounds and vitamin d less-calcemic analogs.

Somjen D, Mirsky N, Tamir S, Vaya J, Posner GH, Kaye AM.

Int J Cell Biol. 2009;2009:273651. doi: 10.1155/2009/273651. Epub 2009 Sep 10.

5.

Coffee drinking and risk of endometrial cancer--a population-based cohort study.

Friberg E, Orsini N, Mantzoros CS, Wolk A.

Int J Cancer. 2009 Nov 15;125(10):2413-7. doi: 10.1002/ijc.24543.

6.

Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women.

Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS.

Cancer. 2009 Jun 15;115(12):2765-74. doi: 10.1002/cncr.24328.

7.

Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies.

Velentzis LS, Cantwell MM, Cardwell C, Keshtgar MR, Leathem AJ, Woodside JV.

Br J Cancer. 2009 May 5;100(9):1492-8. doi: 10.1038/sj.bjc.6605003. Epub 2009 Mar 31.

8.

Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.

Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F.

J Natl Cancer Inst. 2007 Mar 21;99(6):475-86.

9.

NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein.

Rozman KK, Bhatia J, Calafat AM, Chambers C, Culty M, Etzel RA, Flaws JA, Hansen DK, Hoyer PB, Jeffery EH, Kesner JS, Marty S, Thomas JA, Umbach D.

Birth Defects Res B Dev Reprod Toxicol. 2006 Dec;77(6):485-638. Review. No abstract available.

10.

Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans.

Clavel T, Henderson G, Alpert CA, Philippe C, Rigottier-Gois L, Doré J, Blaut M.

Appl Environ Microbiol. 2005 Oct;71(10):6077-85.

11.

Secular trends in age at menarche, smoking, and oral contraceptive use among Israeli girls.

Chodick G, Huerta M, Balicer RD, Davidovitch N, Grotto I.

Prev Chronic Dis. 2005 Apr;2(2):A12. Epub 2005 Mar 15.

12.

Circulating enterolactone and risk of breast cancer: a prospective study in New York.

Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, Koenig KL, Kato I, Arslan AA, Toniolo P.

Br J Cancer. 2004 Jul 5;91(1):99-105.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk